Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00786630
NCT00786630
Completed
Not Applicable

Intervention to Reduce Injection Drug Use

University of Colorado, Denver1 site in 1 country726 target enrollmentNovember 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSubstance Abuse

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Abuse
Sponsor
University of Colorado, Denver
Enrollment
726
Locations
1
Primary Endpoint
Treatment entry and retention
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functioning. The overall goal of this project is to compare strengths-based case-management (CM) to an enhanced version of CM that uses case managers to facilitate a therapeutic alliance (CM/FTA) among out-of-treatment IDUs in Denver.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
February 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •opiate injection at least 3 times a week during the last 6-months
  • •18 years of age or older
  • •no drug abuse treatment in the 30-days prior to the interview
  • •not transient
  • •no known reason (e.g. pending jail time) why they will not be available for follow-up interviews
  • •not involved in Project Safe research activities in the previous 12 months
  • •willing to meet with an Addiction Research and Treatment Services (methadone clinic) counselor
  • •eligible to be treated at ARTS

Exclusion Criteria

  • •too intoxicated or impaired mentally to voluntarily consent to participate in the project and/or respond to the interview

Outcomes

Primary Outcomes

Treatment entry and retention

Time Frame: Baseline, 6 months after baseline, 12 months after baseline

Secondary Outcomes

  • Drug injection and HIV/HCV risk behaviors(Baseline, 6 months after baseline, 12 months after baseline)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseHand, Foot and Mouth Disease
NCT01175915Jiangsu Kanion Pharmaceutical Co., Ltd360
Completed
Not Applicable
HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care ClinicsAlcohol or Other Drugs Use
NCT02294318Research Foundation for Mental Hygiene, Inc.47
Completed
Not Applicable
The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With InductionInduced; Birth
NCT05037617University of Calgary205
Recruiting
Phase 2
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus InfectionComplicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
NCT05655091University Hospital, Basel, Switzerland36
Recruiting
Not Applicable
Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)InsomniaAlcohol UseMarijuana Use
NCT06736444University of Washington800